The NAD+ cycle a biochemist means, and the one on an invoice
Here there is a real cycle. It runs inside every cell you have, it is well characterised, and it has nothing to do with how often you book an appointment. The commercial meaning arrived separately, from a different corner of the market, and the collision is convenient for anyone selling a course of sessions.
In a textbook, the word describes a molecule moving repeatedly between two states. The coenzyme picks up electrons in one reaction and hands them off in another, over and over, so that the same molecules are used again rather than consumed. A second sense of the word covers the salvage route, in which the coenzyme, once broken down, is rebuilt from its own breakdown product rather than made fresh.
On an invoice, the word describes a run of infusions followed by a gap, then more infusions. It is a booking pattern.
Both usages are current. Neither is dishonest on its own. A page that slides from one to the other inside a paragraph, so that a metabolic fact appears to justify a purchasing schedule, is doing something else.
Spending, salvage and turnover, in plain terms
Worth being concrete about the biology, because it is genuinely interesting and it is also the part that gets waved at rather than explained.
The coenzyme is not stored the way fat or glycogen is stored. It is continually broken down by enzymes that consume it as a raw material, including those involved in DNA repair and in adjusting gene activity, and continually rebuilt through the salvage route from a breakdown product. Turnover in tissues is brisk. The pool you have is the running balance of two fast processes rather than a tank that empties.
That has an obvious implication which the market prefers not to draw. A single delivery into that system, however large, is a pulse against a background of constant spending and rebuilding. The idea that a course of infusions establishes a lasting level is an assumption, and for the injected form in humans it has not been demonstrated.
Where on and off periods entered the vocabulary
The idea that a substance should be taken in blocks with breaks between them did not come from metabolism research. It came from anabolic steroid use, where the practice grew up around drugs that suppress the body's own hormone production, so that a break is a real attempt to let something recover.
From there the pattern travelled into the wider grey market, where it became a default way to talk about almost anything sold in vials. Peptide sellers adopted it. Wellness clinics adopted the softer version, the loading course followed by maintenance. In each move it lost the specific problem it was invented to solve and kept the reassuring shape.
There is a second ancestor here as well, and it is closer to home. Aesthetic and infusion clinics were already selling courses with maintenance appointments long before this coenzyme appeared on their menus. The scheduling language was in the building already.
Four sentences with the word in them, sorted by whether they are chemistry
The fourth row is the whole mechanism of this page. Nothing in it is false in isolation. The word does the joining, and no one has to write down the inference the reader makes.
| The sentence | What it means | Is it about biochemistry | What it is doing |
|---|---|---|---|
| The coenzyme cycles between two forms during respiration | Redox cycling inside cells | Yes | Describing a mechanism |
| The salvage cycle rebuilds it from its breakdown product | A metabolic pathway | Yes | Describing a pathway |
| A cycle of six infusions, then monthly maintenance | A booking schedule | No | Selling appointments |
| Your levels are depleted, so you need a cycle | Two claims joined by a word | No | Using row two to justify row three |
What a maintenance interval is actually scheduling
Ask what a monthly session is spaced against and the answers narrow quickly.
It is not spaced against a measured half life for the injected form in humans, because that has not been published. It is not spaced against a duration of effect, because no effect has been characterised well enough to have a duration. It is not spaced against a recovery period, because no suppression has been shown that would need recovering from.
What it does line up with is a month, which is the interval people are used to paying things on, and the point at which someone who felt better after a session might reasonably start wondering whether the feeling has faded.
A provider may answer that clients report the benefit lasting about that long. That is an honest answer and it should be recognised as what it is: an observation about self reports in an uncontrolled setting, which is the weakest form of evidence available and the one most sensitive to expectation.
Tolerance, accumulation and downregulation, and whether any of them apply
Breaks are sometimes defended by borrowing a reason from elsewhere. Three reasons circulate, and they deserve to be checked rather than dismissed.
Tolerance, meaning a diminishing response with repeated exposure, is a real phenomenon for many drugs. For the injected coenzyme in humans, nobody has shown a response reliable enough for a diminishing version of it to be measured.
Accumulation, meaning build up to a harmful level, is the reason some medicines require gaps. This coenzyme is turned over rapidly by the body's own enzymes, so a persistent accumulation from intermittent infusions is not the obvious concern here.
Downregulation, meaning the body reducing its own production in response to supply, is the steroid logic. Whether supplying the finished coenzyme changes the activity of the salvage pathway in people has not been studied in the way that question would need.
So the breaks in a commercial schedule are not answering any of the three. They are the shape the vocabulary arrived in.
What sets the interval for a medicine that has one
For a licensed medicine, the gap between doses is not a preference. It comes from measured work: how quickly the substance is cleared, what concentration is associated with the effect, at what concentration harm begins, and how those numbers behave in the people the medicine is meant for. Regulators require that evidence before permitting an interval, and the interval is then printed rather than negotiated.
Every input to that calculation is missing for the injected form of this coenzyme. That is the reason two providers can offer schedules that differ by a factor of several and neither can be shown to be wrong. Where a real interval exists, plans converge. Where none does, they spread out, and the spread is the tell.
One further asymmetry is worth noticing before the questions. When a licensed medicine's interval turns out to be wrong, there is a mechanism for finding out and changing it: post marketing surveillance, reported harms, updated labelling. A booking convention has no such feedback loop. If a monthly session is too often, too rarely, or pointless, nothing in the arrangement is set up to discover that, and the schedule will persist for as long as it sells.